These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3119210

  • 1. Ifosfamide/mesna and hematuria.
    Pratt CB, Goren MP.
    Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
    [No Abstract] [Full Text] [Related]

  • 2. Ifosfamide, mesna, and encephalopathy.
    Lancet; 1985 Jun 15; 1(8442):1398-9. PubMed ID: 2861351
    [No Abstract] [Full Text] [Related]

  • 3. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E, Flamant F, Ghosn M, Taleb N, Akatchereian C.
    J Clin Oncol; 1987 Aug 15; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract] [Full Text] [Related]

  • 4. Cyclophosphamide and ifosfamide: role of uroprotective agents.
    Williams SD, Munshi N, Einhorn LH, Loehrer PJ.
    Cancer Invest; 1990 Aug 15; 8(2):269. PubMed ID: 2119246
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT.
    J Clin Oncol; 1987 May 15; 5(5):799-803. PubMed ID: 3106585
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide/mesna encephalopathy.
    McCallum AK.
    Lancet; 1987 Apr 25; 1(8539):987. PubMed ID: 2882385
    [No Abstract] [Full Text] [Related]

  • 7. Encephalopathy associated with ifosphamide/mesna therapy.
    Meanwell CA, Blake AE, Latief TN, Blackledge G, Mould JJ, Blake DR, Shaw IC, Honigsberger L, Spooner D, Williams AC.
    Lancet; 1985 Feb 16; 1(8425):406-7. PubMed ID: 2857462
    [No Abstract] [Full Text] [Related]

  • 8. Prediction of ifosfamide/mesna associated encephalopathy.
    Meanwell CA, Blake AE, Kelly KA, Honigsberger L, Blackledge G.
    Eur J Cancer Clin Oncol; 1986 Jul 16; 22(7):815-9. PubMed ID: 3095121
    [Abstract] [Full Text] [Related]

  • 9. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
    Steger GG, Dittrich C, Schlappack O, Mader R, Herold C, Brade WP, Keller A, Moser K.
    J Cancer Res Clin Oncol; 1988 Jul 16; 114(6):602-4. PubMed ID: 3144554
    [Abstract] [Full Text] [Related]

  • 10. Full-dose ifosfamide can be safely administered to outpatients.
    Meazza C, Bisogno G, Casanova M, Zanetti I, Carli M, Ferrari A.
    Pediatr Blood Cancer; 2008 Feb 16; 50(2):375-8. PubMed ID: 16847930
    [Abstract] [Full Text] [Related]

  • 11. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH, de Jong PE, Elema JD, Mulder NH.
    Cancer Chemother Pharmacol; 1989 Feb 16; 23(5):329-30. PubMed ID: 2495864
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
    Burkert H, Schnitker J, Fichtner E.
    MMW Munch Med Wochenschr; 1979 Jun 01; 121(22):760-2. PubMed ID: 112422
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Ghosn M, Carde P, Leclerq B, Flamant F, Friedman S, Droz JP, Hayat M.
    Bull Cancer; 1988 Jun 01; 75(4):391-2. PubMed ID: 3132998
    [Abstract] [Full Text] [Related]

  • 14. CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas.
    Delépine N, Taillard F, Desbois JG, Cornille H, Delépine G, Jasmin C.
    Biomed Pharmacother; 1986 Jun 01; 40(5):173-5. PubMed ID: 3098318
    [Abstract] [Full Text] [Related]

  • 15. [Encephalopathy caused by an ifosfamide-mesna combination].
    Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Livartowski A, Palangie T, Scholl S, Pouillart P.
    Presse Med; 1988 Apr 02; 17(12):591-2. PubMed ID: 2967486
    [No Abstract] [Full Text] [Related]

  • 16. [Epileptic seizures and treatment with ifosfamide-mesna].
    Somma-Mauvais H, Farisse P, Viallat JR.
    Rev Neurol (Paris); 1994 Apr 02; 150(4):307-8. PubMed ID: 7863185
    [Abstract] [Full Text] [Related]

  • 17. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ, Watkin SW.
    Lancet; 1988 May 14; 1(8594):1116. PubMed ID: 2896952
    [No Abstract] [Full Text] [Related]

  • 18. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A, Castel V, Esquembre C, Ferris J, Fernandez JM, Ruiz JG.
    Pediatr Hematol Oncol; 1989 May 14; 6(4):383-5. PubMed ID: 2518327
    [No Abstract] [Full Text] [Related]

  • 19. Continuously improving ifosfamide/mesna: a winning combination.
    Anderson P.
    Pediatr Blood Cancer; 2010 Oct 14; 55(4):599-600. PubMed ID: 20589648
    [No Abstract] [Full Text] [Related]

  • 20. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.